We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Barr to Challenge Patents Protecting Prefest Hormone Therapy

Law360 (December 4, 2003, 12:00 AM EST) -- Generic drugmaker Barr Laboratories said Thursday it is challenging the patents protecting King Pharmaceutical's Prefest hormone therapy.

Each Prefest tablet contains 1 mg estradiol alone or 1 mg estradiol and 0.09...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.